|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/435 | (2006.01) |
| (11) | Number of the document | 2931745 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13849992.6 |
| Date of filing the European patent application | 2013-12-10 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation | 2018-11-12 |
| (86) | Number | PCT/IB2013/003191 |
| Date | 2013-12-10 |
| (87) | Number | WO 2014/091316 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261735823 P | 2012-12-11 | US |
| (72) |
AGORAM, Balaji, GB
ANTONSSON, Madeleine, GB
BEDNAREK, Maria, GB
BURMEISTER, Nicole, GB
BENTHEM, Lambertus, GB
FAIRMAN, David, GB
FRITSCH-FREDIN, Maria, GB
JACKSON, Ronald, GB
LOFMARK, Rasmus, Jansson, GB
METCALFE, Jacqueline, GB
|
| (73) |
MedImmune Limited,
Milstein Building Granta Park, Cambridge CB21 6GH,
GB
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Gliukagono/GLP-1 agonistai nutukimo gydymui |
| GLUCAGON/GLP-1 AGONISTS FOR THE TREATMENT OF OBESITY |
| Payment date | Validity (years) | Amount | |
| 2024-10-25 | 12 | 289.00 EUR |
| 2025-12-10 |